3540 results for «2013»
3540 results
Rapid-fire abstracts: session 4
27 Nov 2022 – From PCR London Valves 2022
In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...
TAVI innovations
27 Nov 2022 – From PCR London Valves 2022
Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!
Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease
28 Nov 2022 – From PCR London Valves 2022
Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.
Tricuspid interventions
27 Nov 2022 – From PCR London Valves 2022
How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!
Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
Rapid-fire clinical cases: session 2
27 Nov 2022 – From PCR London Valves 2022
Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!
Ensuring optimal TAVI outcomes - LIVE case
27 Nov 2022 – From PCR London Valves 2022
A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...
Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning
27 Nov 2022 – From PCR London Valves 2022
In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.
Hot TAVI topics - Emerging indications
27 Nov 2022 – From PCR London Valves 2022
Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...
Primary mitral regurgitation: treatment options when the anatomy is complex
27 Nov 2022 – From PCR London Valves 2022
Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.
Repair vs. replacement for the treatment of tricuspid valve disease
27 Nov 2022 – From PCR London Valves 2022
Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.
Twenty years of progress - What we have achieved - LIVE case
27 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI by axillary access (Live)
An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
TAVI: emerging evidence
27 Nov 2022 – From PCR London Valves 2022
Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...
TAVI step by step: from femoral puncture to procedural success
27 Nov 2022 – From PCR London Valves 2022
Look at these presentations to get insights into the basics of CT evaluation for TAVI procedural planning, and discover how to optimise every aspect of the TAVI procedure and ensure the best clinical outcomes even in difficult anatomies.
TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.
Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.
CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.
Valve-in-valve TAVI: session 1
27 Nov 2022 – From PCR London Valves 2022
ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!
Rapid-fire abstracts: session 3
27 Nov 2022 – From PCR London Valves 2022
Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.
